spirogermanium has been researched along with Melanoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balcerzak, SP; Costanzi, JJ; Fletcher, WS; Goodwin, JW; Kopecky, K; Slavik, M; Tranum, BL | 1 |
Bodurtha, A; Eisenhauer, E; Iscoe, N; Kerr, I; McCulloch, P; Pritchard, K; Quirt, I | 1 |
2 other study(ies) available for spirogermanium and Melanoma
Article | Year |
---|---|
Phase II evaluation of spirogermanium in malignant melanoma: a Southwest Oncology Group Study.
Topics: Aged; Drug Evaluation; Female; Humans; Male; Melanoma; Middle Aged; Organometallic Compounds; Skin Neoplasms; Spiro Compounds | 1987 |
A phase II study of spirogermanium in patients with metastatic malignant melanoma. An NCI Canada Clinical Trials Group Study.
Topics: Adult; Aged; Antineoplastic Agents; Drug Evaluation; Female; Germanium; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Organometallic Compounds; Spiro Compounds | 1985 |